WilmerHale has advised Apellis Pharmaceuticals on the deal.Apellis Pharmaceuticals, Inc., a global biopharmaceutical company, has announced the execution of a capped royalty purchase agreement with Swedish…
Apellis Pharmaceuticals Enters Capped Royalty Purchase Agreement with Sobi for Aspaveli

























